Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Insurance Coverage topic
No spam. Unsubscribe anytime.
Bill Would Expand Public-employee Fertility Benefits; PERS Fiscal Note, Employers Raise Cost Concerns
Summary
House Bill 1282 would change public-employee fertility benefits by removing a $20,000 lifetime cap and specifying rounds of treatment; proponents including patients and medical groups said the cap is inadequate, while business groups warned mandates would raise private-sector costs and PERS provided a neutral fiscal analysis.
Representative Mike Brandenburg presented House Bill 1282 to the House Human Services Committee, describing infertility as a disease and saying the bill aims to expand access to fertility treatments through changes to public-employee benefit rules and by requiring a report to the Legislature.
"A lot of people will say this bill is a mandate. I would beg to differ," Representative Mike Brandenburg said, describing the bill as an effort to standardize and modernize coverage rather than to impose an unfunded requirement. The bill would remove a lifetime dollar cap and instead require coverage for specified cycles and procedures and direct the Public Employees Retirement System (PERS) to provide a report and proposed language for applying the change to the private sector.
Tara Harding (formerly Bradner), an infertility advocate and provider, told the committee PERS's current $20,000 lifetime maximum is insufficient because medication, monitoring and procedures consume that amount quickly. "That $20,000 gets burnt up before someone hardly gets out the door," Harding said, and she urged the committee to revise the cap or coverage design.
Shana Beadle and other patients gave detailed accounts of multi-stage treatment paths—from oral medications and intrauterine insemination (IUI) to IVF—and cited out-of-pocket costs ranging from several thousand dollars for monitoring and drugs to $30,000–$40,000 or more for an IVF cycle in some clinics. Patients and advocates urged the committee to remove the $20,000 limit or replace it with a coverage design that reflects contemporary costs.
Derek Cobine, chief operating and financial officer for PERS, testified in a neutral capacity and summarized Deloitte's actuarial analysis. He said the fiscal note estimates a biennial cost to PERS (examples and ranges were discussed during testimony) and that the actuary used PERS-specific utilization data. Committee members asked whether the fiscal note assumptions reflect realistic utilization; Cobine said the biggest uncertainty is how many members who currently stop at the $20,000 cap would seek additional care if coverage expanded.
Andrea Fenig of the Greater North Dakota Chamber opposed Section 2 of the bill as drafted because it would require PERS to produce language that could extend mandates to private employers; she said employers are already facing rising health-care costs and that additional mandated coverage would increase premiums and employer burdens.
Dr. Anna Tobias, representing the American College of Obstetricians and Gynecologists (North Dakota section), testified in support and described infertility as a common medical condition for which insurance coverage is generally limited. The committee heard both patient impact testimony and neutral fiscal analysis; no committee vote was recorded at the hearing.
